Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013558
Filing Date
2020-11-10
Accepted
2020-11-10 16:52:16
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20200930x10q.htm 10-Q 1626955
2 EX-31.1 osmt-20200930ex31109318b.htm EX-31.1 10540
3 EX-31.2 osmt-20200930ex31217ce88.htm EX-31.2 10453
4 EX-32.1 osmt-20200930ex32185cf81.htm EX-32.1 7202
5 EX-32.2 osmt-20200930ex3225175ad.htm EX-32.2 8290
  Complete submission text file 0001558370-20-013558.txt   7441667

Data Files

Seq Description Document Type Size
6 EX-101.INS osmt-20200930.xml EX-101.INS 1918407
7 EX-101.SCH osmt-20200930.xsd EX-101.SCH 46544
8 EX-101.CAL osmt-20200930_cal.xml EX-101.CAL 58414
9 EX-101.DEF osmt-20200930_def.xml EX-101.DEF 166382
10 EX-101.LAB osmt-20200930_lab.xml EX-101.LAB 401153
11 EX-101.PRE osmt-20200930_pre.xml EX-101.PRE 321644
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 201301867
SIC: 2834 Pharmaceutical Preparations